Reformulation

FDA to Review Oxycontin Reformulation

April 26, 2008

Almost a year after three executives of Purdue Pharm, makers of Oxycontin, were convicted of misrepresenting the powerful pain killer’s potential for abuse and addiction the FDA is scheduled to review an improved version of the drug that may come closer to performing as originally claimed. According to the FDA’s agenda, the meeting will be held on May 5th and is being held to review “The sustained-release characteristics of this formulation are purportedly less easily defeated than other formulations of OXYCONTIN.”

It is really difficult to get any information on what exactly the company has changed in the formulation, most internet searches on Oxycontin will only produce the day’s string of Walgreens, Rexall, and CVS robberies.

TAMPA – A major chain is being hit hard by thieves. CVS pharmacies have been targeted four times in just the last two weeks… In every case, the suspects are looking for either Oxycontin or Hydrocodone. Retired Tampa Police Sergeant Jim Contento said that often it’s the addict who commits the crime. ~ FOX Tampa Bay

Click “Read more” to continue…

1 comment Read the full article →